167 related articles for article (PubMed ID: 37534654)
41. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
42. Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics (Review).
Pekarek L; Garrido-Gil MJ; Sánchez-Cendra A; Cassinello J; Pekarek T; Fraile-Martinez O; García-Montero C; Lopez-Gonzalez L; Rios-Parra A; Álvarez-Mon M; Acero J; Diaz-Pedrero R; Ortega MA
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37859591
[TBL] [Abstract][Full Text] [Related]
43. Temporal and spatial characteristics of tumor evolution in a mouse model of oral squamous cell carcinoma.
Cao Y; Dong H; Li G; Wei H; Xie C; Tuo Y; Chen N; Yu D
BMC Cancer; 2022 Nov; 22(1):1209. PubMed ID: 36424557
[TBL] [Abstract][Full Text] [Related]
44. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
45. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
46. Assessing immuno-expression of p53 protein and TP 53 gene amplification in histologically negative surgical margins of oral squamous cell carcinoma patients and normal oral mucosa.
Kamat MS; Puranik RS; Das Rai AB; Patil BR; Patil S
Clin Oral Investig; 2022 Oct; 26(10):6235-6243. PubMed ID: 35674840
[TBL] [Abstract][Full Text] [Related]
47. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
[TBL] [Abstract][Full Text] [Related]
48. Clues toward precision medicine in oral squamous cell carcinoma: utility of next-generation sequencing for the prognostic stratification of high-risk patients harboring neck lymph node extracapsular extension.
Wang HM; Liao CT; Yen TC; Chen SJ; Lee LY; Hsieh CH; Lin CY; Ng SH
Oncotarget; 2016 Sep; 7(39):63082-63092. PubMed ID: 27590518
[TBL] [Abstract][Full Text] [Related]
49. Targeting the DNA Damage Response in OSCC with TP53 Mutations.
Lindemann A; Takahashi H; Patel AA; Osman AA; Myers JN
J Dent Res; 2018 Jun; 97(6):635-644. PubMed ID: 29489434
[TBL] [Abstract][Full Text] [Related]
50. DNA methylation analysis by bisulfite next-generation sequencing for early detection of oral squamous cell carcinoma and high-grade squamous intraepithelial lesion from oral brushing.
Morandi L; Gissi D; Tarsitano A; Asioli S; Monti V; Del Corso G; Marchetti C; Montebugnoli L; Foschini MP
J Craniomaxillofac Surg; 2015 Oct; 43(8):1494-500. PubMed ID: 26302938
[TBL] [Abstract][Full Text] [Related]
51. Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications.
Osawa Y; Aoyama KI; Hosomichi K; Uchibori M; Tajima A; Kimura M; Ota Y
Cancer Treat Res Commun; 2021; 29():100456. PubMed ID: 34563788
[TBL] [Abstract][Full Text] [Related]
52.
Mustansar T; Mirza T; Hussain M
Biotech Histochem; 2023 Nov; 98(6):382-390. PubMed ID: 37013448
[TBL] [Abstract][Full Text] [Related]
53. Decreased CSTA expression promotes lymphatic metastasis and predicts poor survival in oral squamous cell carcinoma.
Wang Y; Wang L; Li X; Qu X; Han N; Ruan M; Zhang C
Arch Oral Biol; 2021 Jun; 126():105116. PubMed ID: 33831734
[TBL] [Abstract][Full Text] [Related]
54. A Novel Tongue Squamous Cell Carcinoma Cell Line Escapes from Immune Recognition due to Genetic Alterations in
Zheng X; Sun Y; Li Y; Ma J; Lv Y; Hu Y; Zhou Y; Zhang J
Cells; 2022 Dec; 12(1):. PubMed ID: 36611830
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
56. [Application of near infrared fluorescence imaging in detection of residual cancer in oral squamous cell carcinoma].
Zhang Q; Xia CW; Hu SQ; Wang Y; Pu YM; Wang YX
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):450-454. PubMed ID: 35615804
[No Abstract] [Full Text] [Related]
57. Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.
Bruckman KC; Schönleben F; Qiu W; Woo VL; Su GH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Nov; 110(5):632-7. PubMed ID: 20813562
[TBL] [Abstract][Full Text] [Related]
58. Comparison of mutation landscapes of pretreatment versus recurrent squamous cell carcinoma of the oral cavity: The possible mechanism of resistance to standard treatment.
Payungwong T; Angkulkrerkkrai K; Chaiboonchoe A; Lausoontornsiri W; Jirawatnotai S; Chindavijak S
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2004. PubMed ID: 38477073
[TBL] [Abstract][Full Text] [Related]
59. Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma.
Ghantous Y; Bahouth Z; Abu El-Naaj I
Arch Oral Biol; 2018 Nov; 95():141-148. PubMed ID: 30118965
[TBL] [Abstract][Full Text] [Related]
60. The mutational spectrum in whole exon of p53 in oral squamous cell carcinoma and its clinical implications.
Hyodo T; Kuribayashi N; Fukumoto C; Komiyama Y; Shiraishi R; Kamimura R; Sawatani Y; Yaguchi E; Hasegawa T; Izumi S; Wakui T; Nakashiro KI; Uchida D; Kawamata H
Sci Rep; 2022 Dec; 12(1):21695. PubMed ID: 36522371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
